药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dexfenfluramine
Diphenadione
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Diphenadione.
Dexfenfluramine
Clorindione
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Clorindione.
Dexfenfluramine
Ethyl biscoumacetate
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Ethyl biscoumacetate.
Dexfenfluramine
4-hydroxycoumarin
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with 4-hydroxycoumarin.
Dexfenfluramine
Dabigatran
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Dabigatran.
Dexfenfluramine
Edetate calcium disodium anhydrous
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Edetate calcium disodium anhydrous.
Dexfenfluramine
(S)-Warfarin
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with (S)-Warfarin.
Dexfenfluramine
Saruplase
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Saruplase.
Dexfenfluramine
Melagatran
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Melagatran.
Dexfenfluramine
Tioclomarol
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Tioclomarol.
Dexfenfluramine
Brinase
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Brinase.
Dexfenfluramine
Protein S human
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Protein S human.
Dexfenfluramine
Gabexate
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Gabexate.
Dexfenfluramine
Monteplase
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Monteplase.
Dexfenfluramine
Nafamostat
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Nafamostat.
Dexfenfluramine
Betrixaban
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Betrixaban.
Dexfenfluramine
Darexaban
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Darexaban.
Dexfenfluramine
Letaxaban
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Letaxaban.
Dexfenfluramine
Antithrombin III human
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Antithrombin III human.
Dexfenfluramine
Protein C
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Protein C.